|Fluid overload in infants following congenital heart surgery.|
|PMID: 23249789 Owner: NLM Status: MEDLINE|
|OBJECTIVE: To describe postoperative fluid overload patterns and correlate degree of fluid overload with intensive care morbidity and mortality in infants undergoing congenital heart surgery.
DESIGN: Prospective, observational study. Fluid overload (%) was calculated by two methods: 1) (Total fluid in - Total fluid out)/(Preoperative weight) × 100; and 2) (Current weight - Preoperative weight)/(Preoperative weight) × 100. Composite poor outcome included: need for renal replacement therapy, upper quartile time to extubation or intensive care length of stay (> 6.5 and 9.9 days, respectively), or death ≤ 30 days after surgery.
SETTING: University hospital pediatric cardiac ICU.
PATIENTS: Forty-nine infants < 6 months of age undergoing congenital heart surgery with cardiopulmonary bypass during the period of July 2009 to July 2010.
MEASUREMENTS AND MAIN RESULTS: Patients had a median age of 53 days (21 neonates) and mean weight of 4.5 ± 1.3 kg. Forty-two patients (86%) developed acute kidney injury by meeting at least Acute Kidney Injury Network and Kidney Disease Improving Global Outcomes stage 1 criteria (serum creatinine rise of 50% or ≥ 0.3mg/dL). The patients with adverse outcomes (n = 17, 35%) were younger (7 [5 - 10] vs. 98 [33 - 150] days, p = 0.001), had lower preoperative weight (3.7 ± 0.7 vs. 4.9 ± 1.4 kg, p = 0.0002), higher postoperative mean peak serum creatinine (SCr) (0.9 ± 0.3 vs. 0.6 ± 0.3mg/dL, p = 0.005), and higher mean maximum fluid overload by both method 1 (12% ± 10% vs. 6% ± 4%, p = 0.03) and method 2 (24% ± 15% vs. 14% ± 8%, p = 0.02). Predictors of a poor outcome from multivariate analyses were cardiopulmonary bypass time, use of circulatory arrest, and increased vasoactive medication requirements postoperatively.
CONCLUSIONS: Early postoperative fluid overload is associated with suboptimal outcomes in infants following cardiac surgery. Because the majority of patients developed kidney injury without needing renal replacement therapy, fluid overload may be an important risk factor for adverse outcomes with all degrees of acute kidney injury.
|Matthew A Hazle; Robert J Gajarski; Sunkyung Yu; Janet Donohue; Neal B Blatt|
Related Documents :
|24124199 - A novel radiographic index for the diagnosis of posterior acromioclavicular joint dislo...
16476649 - Early ocular prosthesis insertion improves quality of life after enucleation.
11754859 - Improvement of perineal wound healing by local administration of gentamicin-impregnated...
18401909 - Wound closure and gradual involution of an infantile hemangioma using a noncontact, low...
14567939 - Topical oxygen as an adjunct to wound healing: a clinical case series.
20306199 - Rare complication after vac-therapy in the treatment of deep sore ulcers in a paraplegi...
12686009 - Endovascular brachytherapy in peripheral arteries: solution for restenosis or false hope?
15906909 - The clinical value of parenteral immunonutrition in surgical patients.
18485309 - The cardiovascular effect of local anesthesia with articaine plus 1:200,000 adrenalin v...
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't|
|Title: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies Volume: 14 ISSN: 1529-7535 ISO Abbreviation: Pediatr Crit Care Med Publication Date: 2013 Jan|
|Created Date: 2013-01-08 Completed Date: 2013-07-05 Revised Date: 2014-10-18|
Medline Journal Info:
|Nlm Unique ID: 100954653 Medline TA: Pediatr Crit Care Med Country: United States|
|Languages: eng Pagination: 44-9 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Acute Kidney Injury
Cardiopulmonary Bypass / adverse effects
Creatinine / blood
Heart Arrest, Induced / adverse effects
Heart Defects, Congenital / surgery
Intensive Care Units, Pediatric
Length of Stay
Postoperative Complications / etiology, therapy*
Renal Replacement Therapy
Vasoconstrictor Agents / adverse effects
Vasodilator Agents / adverse effects
|K12 HD 028820/HD/NICHD NIH HHS; K12 HD028820/HD/NICHD NIH HHS|
|0/Vasoconstrictor Agents; 0/Vasodilator Agents; AYI8EX34EU/Creatinine|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: End-of-life care decisions in the PICU: roles professionals play.
Next Document: What the patient needs to know before stoma siting: an overview.